![Vaccines | Free Full-Text | Risk of Absence of Measles Antibody in Healthcare Personnel and Efficacy of Booster Vaccination | HTML Vaccines | Free Full-Text | Risk of Absence of Measles Antibody in Healthcare Personnel and Efficacy of Booster Vaccination | HTML](https://www.mdpi.com/vaccines/vaccines-09-00501/article_deploy/html/images/vaccines-09-00501-g001.png)
Vaccines | Free Full-Text | Risk of Absence of Measles Antibody in Healthcare Personnel and Efficacy of Booster Vaccination | HTML
![References in Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial - The Lancet References in Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/124113b6-7543-4d8a-9106-2ac7464b05ee/gr1.jpg)
References in Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial - The Lancet
![Belgian regulators advise against giving AstraZeneca Covid vaccine to over-55s | Belgium | The Guardian Belgian regulators advise against giving AstraZeneca Covid vaccine to over-55s | Belgium | The Guardian](https://i.guim.co.uk/img/media/1c4a1b02da421d4ac20a3c9759f93b3e648f3e66/1274_673_1869_1121/1869.jpg?width=620&quality=85&auto=format&fit=max&s=c46d84ea871f43b7836d6c119a6cf7d2)
Belgian regulators advise against giving AstraZeneca Covid vaccine to over-55s | Belgium | The Guardian
![The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses - EClinicalMedicine The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses - EClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/62943bbd-d370-4caf-817f-a5aa96583489/gr1.jpg)
The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses - EClinicalMedicine
![Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial - eBioMedicine Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b44232ea-1998-454d-8c91-48055c5877d8/gr1_lrg.jpg)
Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial - eBioMedicine
![Opening van het grootste Belgische vaccinatiecentrum op de Heizel | Gemeenschappelijke Gemeenschapscommissie Opening van het grootste Belgische vaccinatiecentrum op de Heizel | Gemeenschappelijke Gemeenschapscommissie](https://www.ccc-ggc.brussels/sites/default/files/centre_de_vaccination_2.png)
Opening van het grootste Belgische vaccinatiecentrum op de Heizel | Gemeenschappelijke Gemeenschapscommissie
![Coronavaccin veilig en werkzaam bij kinderen van 5 tot 11 jaar", maar lang niet zeker of we hen ook zullen vaccineren | VRT NWS: nieuws Coronavaccin veilig en werkzaam bij kinderen van 5 tot 11 jaar", maar lang niet zeker of we hen ook zullen vaccineren | VRT NWS: nieuws](https://images.vrt.be/vrtnws_share/2021/08/15/95ef32e7-fdae-11eb-b07d-02b7b76bf47f.jpg)
Coronavaccin veilig en werkzaam bij kinderen van 5 tot 11 jaar", maar lang niet zeker of we hen ook zullen vaccineren | VRT NWS: nieuws
![SciELO - Saúde Pública - Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets SciELO - Saúde Pública - Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets](https://www.scielosp.org/media/assets/bwho/v86n2/a13tab02.gif)
SciELO - Saúde Pública - Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets
![Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study - eBioMedicine Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/9adf5828-6254-488e-a6c9-e98f1dd3ae7b/gr1.jpg)
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study - eBioMedicine
![Nuvaxovid alternatief voor mensen die niet tegen Covid-19 konden gevaccineerd worden | Zorgnet-Icuro Nuvaxovid alternatief voor mensen die niet tegen Covid-19 konden gevaccineerd worden | Zorgnet-Icuro](https://www.zorgneticuro.be/sites/default/files/styles/social_media_img/public/2022-01/pexels-photo-3952241.jpeg?h=7ad8c004&itok=pRQXVxpF)
Nuvaxovid alternatief voor mensen die niet tegen Covid-19 konden gevaccineerd worden | Zorgnet-Icuro
![Dringende brief 4 : Tweede dosis Vaxzevria® en algemene voorwaarden COVID-19 Vaccine Janssen® | FOD Volksgezondheid Dringende brief 4 : Tweede dosis Vaxzevria® en algemene voorwaarden COVID-19 Vaccine Janssen® | FOD Volksgezondheid](https://www.health.belgium.be/sites/default/files/adobestock_408218490_modifie.jpg)
Dringende brief 4 : Tweede dosis Vaxzevria® en algemene voorwaarden COVID-19 Vaccine Janssen® | FOD Volksgezondheid
![The Impact of 2-Dose Routine Measles, Mumps, Rubella, and Varicella Vaccination in France on the Epidemiology of Varicella and Zoster Using a Dynamic Model With an Empirical Contact Matrix - Clinical Therapeutics The Impact of 2-Dose Routine Measles, Mumps, Rubella, and Varicella Vaccination in France on the Epidemiology of Varicella and Zoster Using a Dynamic Model With an Empirical Contact Matrix - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1248bc47-98a6-427f-9df4-1aef5d6ddb17/gr1.jpg)